filings.toolsItem 5. OTHER INFORMATION
2K characters. Original on sec.gov ·
Item 5. OTHER INFORMATION
On April 14, 2024, the Company entered into an amendment to the indemnification and reimbursement agreement with Resideo, which is filed herewith as Exhibit 10.3. The amendment provides that certain covenants set forth in Exhibit G of the indemnification and reimbursement agreement will be modified to substantially conform the covenants with those contained in Resideo's credit agreement (as and when such covenants in the credit agreement are amended in connection with the acquisition and financing transactions that Resideo announced on April 15, 2024).
EQUITY TRADING PLAN ELECTIONS
Certain executive officers and directors of the Company execute purchases and sales of the Company's common stock through Rule 10b5-1 and non-Rule 10b5-1 equity trading plans. The following table describes an equity trading plan adopted by one of our directors during the three months ended March 31, 2024:
| Name and title | Action | Plan Type | Date of adoption of Rule 10b5-1 trading plan | Scheduled expiration of Rule 10b5-1 trading plan | Aggregate number of securities to be purchased or sold | ||||||||||||
| Grace D. Lieblein Director | Adoption | Rule 10b5-1 | 2/5/2024 | 5/6/2025 | 6,441 stock options and associated sale of shares to cover option exercise costs and tax obligations. | ||||||||||||
During the three months ended March 31, 2024, none of our executive officers or directors terminated or modified a "Rule 10b5-1 trading agreement", or adopted, terminated, or modified any "non-Rule 10b5-1 trading arrangement" (as defined in Item 408(c) of Regulation S-K).
49 Honeywell International Inc.
Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS